$405 Million is the total value of Sands Capital Ventures, LLC's 23 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 4.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DICE THERAPEUTICS INC | $78,757,991 | +91726.8% | 2,748,970 | 0.0% | 19.47% | -17.1% | ||
| PATH | UIPATH INCcl a | $67,018,952 | +138057.8% | 3,816,569 | 0.0% | 16.56% | +24.7% | |
| Buy | SAMSARA INC | $45,252,983 | +1094818.5% | 2,294,776 | +590.1% | 11.18% | +888.1% | |
| NU HLDGS LTD | $43,584,212 | +116854.4% | 9,156,347 | 0.0% | 10.77% | +5.5% | ||
| DASH | DOORDASH INCcl a | $38,359,223 | +130094.6% | 603,512 | 0.0% | 9.48% | +17.5% | |
| SNOW | SNOWFLAKE INCcl a | $33,254,895 | +107388.8% | 215,535 | 0.0% | 8.22% | -3.0% | |
| TXG | 10X GENOMICS INC | $26,877,948 | +152998.4% | 481,770 | 0.0% | 6.64% | +38.2% | |
| ACRIVON THERAPEUTICS INC | $20,971,557 | +110056.3% | 1,652,605 | 0.0% | 5.18% | -0.6% | ||
| OLK | OLINK HLDG ABsponsored ads | $15,895,230 | +88670.4% | 705,514 | 0.0% | 3.93% | -19.9% | |
| ABOS | ACUMEN PHARMACEUTICALS INC | $13,873,325 | +75086.0% | 3,417,075 | 0.0% | 3.43% | -32.2% | |
| KRTX | KARUNA THERAPEUTICS INC | $10,697,688 | +92336.6% | 58,895 | 0.0% | 2.64% | -16.6% | |
| TARS | TARSUS PHARMACEUTICALS INC | $3,268,200 | +85634.5% | 260,000 | 0.0% | 0.81% | -22.6% | |
| MASS | 908 DEVICES INC | $2,807,272 | +112777.8% | 326,427 | 0.0% | 0.69% | +1.9% | |
| SPRB | SPRUCE BIOSCIENCES INC | $1,739,285 | +200741.2% | 787,007 | 0.0% | 0.43% | +81.4% | |
| CANDEL THERAPEUTICS INC | $1,095,845 | +75319.5% | 811,737 | 0.0% | 0.27% | -31.9% | ||
| TSHA | TAYSHA GENE THERAPIES INC | $579,898 | +35302.8% | 724,873 | 0.0% | 0.14% | -68.2% | |
| CRWD | CROWDSTRIKE HLDGS INCcl a | $118,593 | +130222.0% | 864 | 0.0% | 0.03% | +16.0% | |
| CPNG | COUPANG INCcl a | $111,536 | +108187.4% | 6,971 | 0.0% | 0.03% | 0.0% | |
| ABSCI CORPORATION | $101,157 | +83500.8% | 57,804 | 0.0% | 0.02% | -24.2% | ||
| DDOG | DATADOG INC | $99,254 | +99154.0% | 1,366 | 0.0% | 0.02% | -7.4% | |
| TOAST INCcl a | $79,769 | +98380.2% | 4,494 | 0.0% | 0.02% | -9.1% | ||
| CFLT | CONFLUENT INC | $32,591 | +108536.7% | 1,354 | 0.0% | 0.01% | 0.0% | |
| GITLAB INC | $22,563 | +75110.0% | 658 | 0.0% | 0.01% | -25.0% | ||
| Exit | SAMSARA, INC. | $0 | – | -2,712,256 | -100.0% | -9.23% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UIPATH INC | 9 | Q3 2023 | 30.2% |
| DOORDASH INC | 9 | Q3 2023 | 19.6% |
| SNOWFLAKE INC | 9 | Q3 2023 | 14.4% |
| ACUMEN PHARMACEUTICALS, INC | 9 | Q3 2023 | 10.0% |
| 908 DEVICES INC | 9 | Q3 2023 | 1.8% |
| TARSUS PHARMACEUTICALS INC | 9 | Q3 2023 | 1.4% |
| TAYSHA GENE THERAPIES INC | 9 | Q3 2023 | 2.0% |
| CANDEL THERAPEUTICS, INC | 9 | Q3 2023 | 1.3% |
| SPRUCE BIOSCIENCES INC | 9 | Q3 2023 | 0.7% |
| ABSCI CORPORATION | 9 | Q3 2023 | 0.1% |
View Sands Capital Ventures, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-15 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-09 |
View Sands Capital Ventures, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.